Classificationa
| Codon 129 genotype | PrPSctype | Transmission typeb
| Original PrPSc
| Existing PrPSc
|
---|
np-dCJD | M/M | 1 | M1 | M1 | M1 |
p-dCJD | M/M | i c
| V2 | V2 d
| Mi |
sCJD-MM1 | M/M | 1 | M1 | M1 | M1 |
sCJD-VV2 | V/V | 2 | V2 | V2 | V2 |
sCJD-MV2K | M/V | i + 2 | V2 | V2 | Mi + V2 |
sCJD-MV2K+C | M/V | i + 2 | V2 | M2Ce + V2 | M2C + Mi + V2 |
-
aAccording to Parchi, 1999 [17]; and Parchi, 2011 [18].
-
bAccording to Bishop, 2010 [24]; Kobayashi, 2007 [20]; and Kobayashi, 2013 [23].
-
cIntermediate type located between types 1 and 2 PrPSc.
-
dAlthough not only V2 PrPSc but also Mi PrPSc can cause p-dCJD if transmitted to the 129Â M/M individuals, the primary origin of Mi PrPSc is V2 PrPSc (see text).
-
eM2 PrPSc can be divided into two subgroups based on histopathological phenotypes. M2C PrPSc causes a predominant cortical pathology, whereas M2T PrPSc causes atrophy of thalamic and inferior olivery nuclei.